William Marks, JR, MD
|
| Title | Professor of Clinical |
|---|
| School | UCSF School of Medicine |
|---|
| Department | Neurology |
|---|
| Address | 4150 Clement Street San Francisco CA 94143
|
|---|
| Phone | 415-750-2100 |
|---|
|
|
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Researchers can login to make corrections and additions, or contact us for help.
-
Markun LC, Starr PA, Air EL, Marks WJ, Volz MM, Ostrem JL. Shorter disease duration correlates with improved long-term deep brain stimulation outcomes in young-onset DYT1 dystonia. Neurosurgery. 2012 Aug; 71(2):325-30.
-
Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology. 2012 Jul 3; 79(1):55-65.
-
Christine CW, Marks WJ, Ostrem JL. Development of Parkinson's disease in patients with Narcolepsy. J Neural Transm. 2012 Jun; 119(6):697-9.
-
Zhan W, Kang GA, Glass GA, Zhang Y, Shirley C, Millin R, Possin KL, Nezamzadeh M, Weiner MW, Marks WJ, Schuff N. Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging. Mov Disord. 2012 Jan; 27(1):90-7.
-
Witt J, Marks WJ. An update on gene therapy in Parkinson's disease. Curr Neurol Neurosci Rep. 2011 Aug; 11(4):362-70.
-
Bronte-Stewart H, Taira T, Valldeoriola F, Merello M, Marks WJ, Albanese A, Bressman S, Moro E. Inclusion and exclusion criteria for DBS in dystonia. Mov Disord. 2011 Jun; 26 Suppl 1:S5-16.
-
Marks WJ, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, Tagliati M, Alterman R, Stern M, Baltuch G, Starr PA, Larson PS, Ostrem JL, Nutt J, Kieburtz K, Kordower JH, Olanow CW. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol. 2010 Dec; 9(12):1164-72.
-
Bronstein JM, Tagliati M, Alterman RL, Lozano AM, Volkmann J, Stefani A, Horak FB, Okun MS, Foote KD, Krack P, Pahwa R, Henderson JM, Hariz MI, Bakay RA, Rezai A, Marks WJ, Moro E, Vitek JL, Weaver FM, Gross RE, DeLong MR. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol. 2011 Feb; 68(2):165.
-
Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med. 2010 Jun 3; 362(22):2077-91.
-
Fisher R, Salanova V, Witt T, Worth R, Henry T, Gross R, Oommen K, Osorio I, Nazzaro J, Labar D, Kaplitt M, Sperling M, Sandok E, Neal J, Handforth A, Stern J, DeSalles A, Chung S, Shetter A, Bergen D, Bakay R, Henderson J, French J, Baltuch G, Rosenfeld W, Youkilis A, Marks W, Garcia P, Barbaro N, Fountain N, Bazil C, Goodman R, McKhann G, Babu Krishnamurthy K, Papavassiliou S, Epstein C, Pollard J, Tonder L, Grebin J, Coffey R, Graves N. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010 May; 51(5):899-908.
-
Berman BD, Starr PA, Marks WJ, Ostrem JL. Induction of bradykinesia with pallidal deep brain stimulation in patients with cranial-cervical dystonia. Stereotact Funct Neurosurg. 2009; 87(1):37-44.
-
Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein J, Stoner G, Heemskerk J, Huang GD. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009 Jan 7; 301(1):63-73.
-
Stanslaski S, Cong P, Carlson D, Santa W, Jensen R, Molnar G, Marks WJ, Shafquat A, Denison T. An implantable bi-directional brain-machine interface system for chronic neuroprosthesis research. Conf Proc IEEE Eng Med Biol Soc. 2009; 2009:5494-7.
-
Marks WJ, Ostrem JL, Verhagen L, Starr PA, Larson PS, Bakay RA, Taylor R, Cahn-Weiner DA, Stoessl AJ, Olanow CW, Bartus RT. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurol. 2008 May; 7(5):400-8.
-
Ostrem JL, Marks WJ, Volz MM, Heath SL, Starr PA. Pallidal deep brain stimulation in patients with cranial-cervical dystonia (Meige syndrome). Mov Disord. 2007 Oct 15; 22(13):1885-91.
-
Nakamura K, Christine CW, Starr PA, Marks WJ. Effects of unilateral subthalamic and pallidal deep brain stimulation on fine motor functions in Parkinson's disease. Mov Disord. 2007 Apr 15; 22(5):619-26.
-
Khandhar SM, Marks WJ. Epidemiology of Parkinson's disease. Dis Mon. 2007 Apr; 53(4):200-5.
-
Rothlind JC, Cockshott RW, Starr PA, Marks WJ. Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson's disease. J Int Neuropsychol Soc. 2007 Jan; 13(1):68-79.
-
Starr PA, Turner RS, Rau G, Lindsey N, Heath S, Volz M, Ostrem JL, Marks WJ. Microelectrode-guided implantation of deep brain stimulators into the globus pallidus internus for dystonia: techniques, electrode locations, and outcomes. J Neurosurg. 2006 Apr; 104(4):488-501.
-
Follett K, Weaver F, Stern M, Marks W, Hogarth P, Holloway K, Bronstein J, Duda J, Horn S, Lai E, Samii A. Multisite randomized trial of deep brain stimulation. Arch Neurol. 2005 Oct; 62(10):1643-4; author reply 1644-5.
-
Marks WJ. When epilepsy surgery fails ... There is often a second chance. Epilepsy Curr. 2005 Jul-Aug; 5(4):149-51.
-
Rowan AJ, Ramsay RE, Collins JF, Pryor F, Boardman KD, Uthman BM, Spitz M, Frederick T, Towne A, Carter GS, Marks W, Felicetta J, Tomyanovich ML. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology. 2005 Jun 14; 64(11):1868-73.
-
Marks WJ. Focal cortical dysplasia: a clearer view of surgical outcome. Epilepsy Curr. 2005 Mar-Apr; 5(2):55-6.
-
Starr PA, Rau GM, Davis V, Marks WJ, Ostrem JL, Simmons D, Lindsey N, Turner RS. Spontaneous pallidal neuronal activity in human dystonia: comparison with Parkinson's disease and normal macaque. J Neurophysiol. 2005 Jun; 93(6):3165-76.
-
Piper M, Abrams GM, Marks WJ. Deep brain stimulation for the treatment of Parkinson's disease: overview and impact on gait and mobility. NeuroRehabilitation. 2005; 20(3):223-32.
-
Marks WJ. More long-term outcome data on temporal lobectomy. Epilepsy Curr. 2005 Jan-Feb; 5(1):37-8.
-
Marks WJ. Utility of MEG in presurgical localization. Epilepsy Curr. 2004 Sep-Oct; 4(5):208-9.
-
Starr PA, Turner RS, Rau G, Lindsey N, Heath S, Volz M, Ostrem JL, Marks WJ. Microelectrode-guided implantation of deep brain stimulators into the globus pallidus internus for dystonia: techniques, electrode locations, and outcomes. Neurosurg Focus. 2004 Jul 15; 17(1):E4.
-
Marks WJ. First findings from the multicenter study of epilepsy surgery. Epilepsy Curr. 2004 Jul-Aug; 4(4):141-2.
-
French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2004 May; 45(5):410-23.
-
French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2004 May; 45(5):401-9.
-
French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004 Apr 27; 62(8):1252-60.
-
French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004 Apr 27; 62(8):1261-73.
-
Theodosopoulos PV, Marks WJ, Christine C, Starr PA. Locations of movement-related cells in the human subthalamic nucleus in Parkinson's disease. Mov Disord. 2003 Jul; 18(7):791-8.
-
O'Neill J, Schuff N, Marks WJ, Feiwell R, Aminoff MJ, Weiner MW. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease. Mov Disord. 2002 Sep; 17(5):917-27.
-
Starr PA, Christine CW, Theodosopoulos PV, Lindsey N, Byrd D, Mosley A, Marks WJ. Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg. 2002 Aug; 97(2):370-87.
-
Marks WJ. Surgical treatment of Parkinson's disease: ablation, stimulation and transplantation. Expert Rev Neurother. 2001 Nov; 1(2):239-46.
-
Alsaadi TM, Laxer KD, Barbaro NM, Marks WJ, Garcia PA. False lateralization by subdural electrodes in two patients with temporal lobe epilepsy. Neurology. 2001 Aug 14; 57(3):532-4.
-
Alsaadi TM, Laxer KD, Barbaro NM, Marks WJ, Garcia PA. Vagus nerve stimulation for the treatment of bilateral independent temporal lobe epilepsy. Epilepsia. 2001 Jul; 42(7):954-6.
-
Byrd DL, Marks WJ, Starr PA. Deep brain stimulation for advanced Parkinson's disease. AORN J. 2000 Sep; 72(3):387-90, 393-408; quiz 409-14, 416-8.
-
Goodin DS, Aminoff MJ, Kutukcu Y, Marks WJ. Order effects in response times of parkinsonian patients and normal controls. Muscle Nerve. 1999 May; 22(5):567-72.
-
Kutukcu Y, Marks WJ, Goodin DS, Aminoff MJ. Simple and choice reaction time in Parkinson's disease. Brain Res. 1999 Jan 9; 815(2):367-72.
-
Kutukcu Y, Marks WJ, Goodin DS, Aminoff MJ. Cerebral accompaniments to simple and choice reaction tasks in Parkinson's disease. Brain Res. 1998 Jul 13; 799(1):1-5.
-
Marks WJ, Laxer KD. Semiology of temporal lobe seizures: value in lateralizing the seizure focus. Epilepsia. 1998 Jul; 39(7):721-6.
-
Marks WJ, Garcia PA. Management of seizures and epilepsy. Am Fam Physician. 1998 Apr 1; 57(7):1589-600, 1603-4.
-
Schaefer GB, Thompson JN, Bodensteiner JB, Hamza M, Tucker RR, Marks W, Gay C, Wilson D. Quantitative morphometric analysis of brain growth using magnetic resonance imaging. J Child Neurol. 1990 Apr; 5(2):127-30.
|
William's Networks
Click the "See All" links for more information and interactive visualizations!
Related Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Related Authors People who share similar concepts with this person. _
|